References
-
Betti, L., Floridi, M., Giannaccini, G., Manetti, F., Strappaghetti, G., Tafi, A., and Botta, M.,
${\alpha}_1$ -Adrenoceptor antagonists. 5. Pyridazinone-arylpiperazines. Probing the influence on affinity and selectivity of both ortho-Alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus. Bioorg. Med. Chem. Lett., 13, 171-173 (2003) https://doi.org/10.1016/S0960-894X(02)00932-0 - Cignarella, G., Barlocco, D., Pinna, G. A., Loriga, M., Curzu, M., Tofanetti, O., Germini, M., Cazzulani, P., and Cavalletti, E., Synthesis and biological evaluations of substituted benzo[h]-cinnolinones and 3-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and anti-thrombotic 5H-indeno[1,2-c]pyridazinones. J. Med. Chem., 32, 2277-2282 (1989) https://doi.org/10.1021/jm00130a009
- Combs, D. W., Rampulla. M. S., Bell, S. C., Klaubert, D. H., Tobia, A. J., Falotico, R., Haertlein, B., Lakas-Weiss, C., and Moore, J. B., 6- Benzoxazinylpyridazin-3-ones, Potent, long-acting positive inotrope and peripheral vasodilator agents. J. Med. Cham., 33, 380-386 (1990) https://doi.org/10.1021/jm00163a061
- Corsano, S., Vezza, R., Scapicchi, R., Foresi, S., Strappaghetti, G., Nenci, G. G., and Gresele, P., New pyridazinone derivatives as inhibitors of platelet aggregation. Eur. J. Med. Chem., 30, 627-631 (1995) https://doi.org/10.1016/0223-5234(96)88278-X
- Curran, W. V. and Ross, A., 6-Phenyl-4,5-dihydro-3-(2H)-pyridazinones, A series of hypotensive agents, J. Med.Chem., 17, 273-281 (1974) https://doi.org/10.1021/jm00249a004
- Demirayak, S., Benkli, K., Karaburun, A. C., Erol, K., and Boydag, S., Some 1-substituted 3-aryl-1,4-dihydro-1,2,4-triazino[4,3-a]benzimidazoles and their vasodilatory activities. Farmaco, 52, 741-744 (1997)
- Foye, W. O., Lemke, T. L., and Williams, D. A., Principles of Medicinal Chemistry, 4th Ed., Williams and Wilkins. London, 345-387, 499-534 (1995)
- Haikala, H. O., Honkanen, E. J., Lonnberg, K. K., Nore, P. T., Pystynen, J. J., Luiro, A. M., and Pippuri, A. K., Preparation of arylazinones for treatment of congestive heart failure, Brit. UK Pat. Appl., EP 597, 540. C.A. 121, 114, 228967 (1997)
- Heinisch, G. and Kopelent-Frank, H., Pharmacologically active pyridazine derivatives, Part II. Prog. Med. Chem., 29, 141-183 (1992) https://doi.org/10.1016/S0079-6468(08)70007-9
- Laguna, R., Rodriguez-Linarez, B., Cano, E., Estevez, I., Ravina, E., and Sotelo, E., Pyridazines. XIII. Synthesis of 6-aryl- 5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors. Chem. Pharm. Bull., 45, 1151-1155 (1997) https://doi.org/10.1248/cpb.45.1151
- McEvoy, F. J. and Allen, Jr. G. R., 6-(Substituted phenyl)-5-substituted-4,5-dihydro-3(2H)-pyridazinones. J. Med. Chem., 17, 281-286 (1974) https://doi.org/10.1021/jm00249a005
- Montero-Lastres, A., Fraiz, N., Laguna, R., Cano, E., Esteves, I., and Ravina, E. Pyridazines XVIII. 6-aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets. Biol. Pharm. Bull., 22, 1376-1379 (1999) https://doi.org/10.1248/bpb.22.1376
-
Seki, T., Nakao, T., Masuda, T., Hasumi, K., Gotanda, K., Ishimori, T., Honma, S., Minami, N., Shibata, K., and Yasuda, K., Studies on agents with vasodilator and
${\beta}$ -blocking activities. IV, Chem. Pharm. Bull., 44, 2061-2069 (1996) https://doi.org/10.1248/cpb.44.2061 - Sircar, I., Weishaar, R. E., Kobylarz, D., Moos, W. H., and Bristol, J. A., Cardiotonic agents, 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H)-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds, Structure-activity relationships and correlation with in vivo positive inotropic activity. J. Med. Chem., 30, 1955-1962 (1987) https://doi.org/10.1021/jm00394a005
- Sotelo, E., Fraiz, N., Yanez, M., Terrades, V., Laguna, R., Cano, E., and Ravina, E. Pyridazines. Part XXIX: Synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions. Bioorg. Med. Chem., 10, 2873-2882 (2002) https://doi.org/10.1016/S0968-0896(02)00146-3
- Sotelo, E., Fraiz, N., Yanez, M., R. Laguna, E. Cano, and E. Ravina, Pyridazines. Part 31: Synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones. Chem. Pharm. Bull., 50, 1574-1577 (2002) https://doi.org/10.1248/cpb.50.1574
- Szasz, G. and Budvavi-Bavauy, Z., Pharmaceutical Chemistry of Antihypertensive Agents, CRC Press, Boca Raton, 3-265 (1991)
-
Thyes, M., Lehmann, H. D., Gries, J., K
$\ddot{o}$ nig, H., Kretzschmar, R., Kunze, J., Lebk$\ddot{u}$ cher, R., and Lenke, D., 6-Phenyl-4,5-dihydro-3-(2H)-pyridazinones. J. Med. Chem., 26, 800-807 (1983) https://doi.org/10.1021/jm00360a004 - Tishler, M. and Stanovnik, B., Pyridazines. Adv. Heterocyclic Chem., 9, 121 (1968)
- Tishler, M. and Stanovnik, B., Recent advances in pyridazine chemistry. Adv. Heterocyclic Chem., 24, 363 (1979) https://doi.org/10.1016/S0065-2725(08)60515-2
- Tishler, M. and Stanovnik, B., Advances in pyridazine chemistry. Adv. Heterocyclic Chem., 49, 385 (1990) https://doi.org/10.1016/S0065-2725(08)60557-7
- Turcki, I. J., Ed., The Chemistry of Heterocyclic Compounds, Oxazoles, An Intersciences Pub., John Wiley and Sons, p.361-729 (1986)
- Van der Mey, M., Boss, H., Couwenberg, D., Hatzelmann, A., Sterk, G. J., Goubitz, K., Schenk, H., and Timmerman, H., Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones. J. Med. Chem., 45, 2526-2533 (2002) https://doi.org/10.1021/jm0110338
- Wolf, M.E., Burger's Medicinal Chemistry And Drug Discovery 5th ed. Vol. 2, p. 152-462. John Wiley and Sons, New York (1997)
-
Yamaguchi, M., Kamei, K., Koga, T., Akima, M., Maruyama, A., Kurokki, T., and Ohi, N., Novel antiasthmatic agents with dual activities of thromboxane
$A_{2}$ synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones. J. Med. Chem., 36, 4061-4068 (1993) https://doi.org/10.1021/jm00077a009 - Zwieten, P. A. V. and Greenlee, W. J., Antihypertensive drugs, Harwood Academic Publishers, p.1-528 (1997)